ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,094 | -19.9% | 90,379 | -1.0% | 0.00% | – |
| Q1 2023 | $57,541 | +95801.7% | 91,335 | 0.0% | 0.00% | – |
| Q4 2022 | $60 | -100.0% | 91,335 | 0.0% | 0.00% | – |
| Q3 2022 | $157,000 | +20.8% | 91,335 | -13.3% | 0.00% | – |
| Q2 2022 | $130,000 | +88.4% | 105,342 | 0.0% | 0.00% | – |
| Q1 2022 | $69,000 | -40.0% | 105,342 | 0.0% | 0.00% | – |
| Q4 2021 | $115,000 | -39.5% | 105,342 | +1.2% | 0.00% | – |
| Q3 2021 | $190,000 | -57.8% | 104,126 | -38.9% | 0.00% | – |
| Q2 2021 | $450,000 | -27.5% | 170,295 | -1.3% | 0.00% | – |
| Q1 2021 | $621,000 | +750.7% | 172,486 | +494.8% | 0.00% | – |
| Q4 2020 | $73,000 | -47.1% | 29,000 | +89.5% | 0.00% | – |
| Q3 2015 | $138,000 | -45.2% | 15,302 | -27.2% | 0.00% | – |
| Q2 2015 | $252,000 | – | 21,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |